Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
QTRXthis companyQuanterix Corporation	$3.31	-2.53×	0.92×	1.96×	-2.98×	-844.7%	46.7%	-79.2%	-77.3%	-36.2%	-29.8%	-29.4%	0.13×	-0.08×	0×	2.84×	0.0%	2	-2.21	3	B
CVRXCVRx, Inc.	$0.81	-3.48×	4.71×	3.27×	-3.43×	-11723.2%	85.3%	-90.5%	-94.1%	-135.6%	-56.0%	-22.0%	1.29×	0.53×	-8.8×	7.63×	0.0%	3	-9.03	1	D+
IMRXImmuneering Corporation	$3.59	-5.18×	1.33×	0×	-2.96×	-19.7%	0.0%	0.0%	0.0%	-25.6%	-26.7%	-15.7%	0.02×	2.24×	0×	17.5×	0.0%	0	6.81	2	B-
INGNInogen, Inc.	$5.98	-7.91×	0.95×	0.52×	-35.43×	-203.4%	47.6%	-8.7%	-6.5%	-11.8%	-12.3%	-11.8%	0.09×	31.71×	0×	3.12×	0.0%	3	1.53	2	C
MASS908 Devices Inc.	$11.61	-5.2×	1.32×	3.38×	-3.25×	-184.4%	47.7%	-43.0%	-65.2%	-25.5%	-14.0%	-13.0%	0.12×	3.33×	0×	4.24×	0.0%	3	2.13	2	C
OMOutset Medical, Inc.	$4.20	-0.69×	0.44×	0.47×	-1.97×	-1772.3%	39.1%	-55.8%	-68.3%	-64.3%	-29.2%	-83.5%	0.8×	-1.06×	-4.78×	6.67×	0.0%	3	-6.08	2	C
Peer median	—	-5.18×	1.32×	0.52×	-3.25×	-203.4%	47.6%	-43.0%	-65.2%	-25.6%	-26.7%	-15.7%	0.12×	2.24×	0×	6.67×	0.0%	3	1.53	2	—